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Refining the Assessment
of Stroke Risk After
the Maze Procedure*
Shunichi Homma, MD, Marco Di Tullio, MD
New York, New York
Atrial fibrillation is the most common significant arrhyth-
mia in the general population, with an estimated prevalence
of 3% to 4%, which increases to almost 9% after the age of
80 years (1). Atrial fibrillation increases the risk for death by
almost 2-fold and the risk for ischemic stroke by approxi-
mately 5-fold (1). Almost 1 in 4 strokes occurring after age
80 are due to atrial fibrillation (1).
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Although the restoration of sinus rhythm in patients with
atrial fibrillation does not appear to confer a survival benefit
over heart rate control (2), it may still be desirable in many
patients, for symptomatic relief, improvement in left ven-
tricular systolic function, and avoidance of anticoagulant
treatment. Pharmacologic cardioversion with antiarrhyth-
mic drugs has a low success rate and is often complicated by
side effects that negatively affect its risk/benefit ratio (3).
Transcatheter and surgical techniques for atrial fibrillation
ablation have therefore been developed. In 1987, James Cox
introduced the first surgical treatment of atrial fibrillation,
consisting of numerous appropriately placed incisions in the
left and right atrial walls to direct the propagation of the
sinus impulse and eliminate macro–re-entrant circuits (4),
which became known as the Maze procedure. Technical
refinements and simplifications led to the Cox Maze III
procedure, which has been the mainstay of surgical atrial
fibrillation treatment for the past 2 decades. Although also
adopted for lone atrial fibrillation, the procedure has found
its largest application in patients undergoing surgery for
other cardiac indications, especially concomitant mitral
valve disease, for which its use in combination with mitral
valve repair is especially attractive because of the possibility
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paper to disclose.to avoid lifelong anticoagulation. Despite its high success
rates in restoring sinus rhythm (90% in some series [3]),
the Cox Maze III procedure is technically challenging and
time consuming, which has led to the introduction of
modified techniques aimed at reducing or eliminating the
surgical incisions, replacing them with lesions produced by
energy sources such as radiofrequency, laser, and cryoablation.
In this issue of the Journal, Buber et al. (5) report on the
ncidence of stroke in 150 patients who underwent a
odified Maze procedure by radiofrequency or cryoabla-
ion, without the use of atrial incisions. These patients were
he ones who maintained sinus rhythm at 3 months from
he procedure and during the follow-up, among an initial
roup of 236 patients. The investigators looked at the
bsence of left atrial mechanical activity (LAMC) at 3
onths, revealed by the absence of an atrial wave on
ransthoracic Doppler examination of the mitral inflow, and
t left atrial volume as potential predictors of ischemic
troke in a retrospective analysis. Over a mean follow-up
eriod of 24.5 months, 15 strokes occurred (10%). The 47
atients (31%) with no detectable LAMC had a signifi-
antly higher incidence of stroke than those with normal
AMC (21% vs. 5%), as did patients with atrial volume
ndexes in the upper quartile of the distribution (33
l/m2) compared with those with smaller atria (23% vs.
6%). In a multivariate analysis adjusted for an established
stroke risk score (CHA2DS2-VASc), the absence of LAMC
carried an almost 5-fold increase in stroke risk; large atrial
volume carried a 3-fold increase. These results persisted
when patients with prosthetic valves, who were also the only
ones on chronic systemic anticoagulation therapy, were
excluded from the analysis. The investigators suggested that
LAMC absence and LA volume index33 ml/m2 could be
used to identify patients at higher stroke risk who could
benefit from anticoagulant treatment.
This study has important merits. First, it reminds us that,
after a successful Maze procedure, ischemic stroke may still
occur, despite the persistence of sinus rhythm (or at least the
absence of documented atrial fibrillation recurrence) and the
surgical excision of the left atrial appendage, which is the most
common location for thrombus formation. Second, it shows
that even with the less extensive atrial lesions afforded by the
use of radiofrequency and cryoablation compared with
surgical incisions, residual atrial dysfunction may still occur
and last for a long time (no changes were seen in LAMC
between 3 and 12 months). Finally, the study demonstrates
the feasibility of performing post-operative stroke risk
stratification on the basis of simply obtained echocardio-
graphic indicators of atrial morphology and function. How-
ever, several circumstances prevent the general applicability
of the results. First, the incidence of stroke (10% over 2
years) was unusually high for patients undergoing the Maze
procedure. Very low stroke rates have been reported for the
classic Cox Maze III procedure, although the comparison
across studies is complicated by differences in surgical
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egies. Stroke surveillance and adjudication methods have
also differed. In 265 patients followed for up to 11.5 years
after surgery, only 1 stroke was reported (6). Over a mean
follow-up period of 4 years, no strokes were reported in 139
patients undergoing the procedure for lone atrial fibrillation,
and 2 strokes were reported in 64 patients (3%) with
concomitant cardiac surgery (7). In a recent series of 435
patients with concomitant mitral valve repair or replace-
ment, 6 strokes (1.4%) occurred over a mean follow-up
period of 40.6 months (8). Recently, a study that used
radiofrequency ablation in 258 patients with longstanding
atrial fibrillation, and is therefore more closely comparable
with the study of Buber et al. (5), reported a stroke
incidence of 1.6% over a mean follow-up period of 43.7
months; however, almost all patients were chronically anti-
coagulated (9). The stroke rate observed in the study of
Buber et al. (5) appears to be at the high end of those
reported for similar procedures, possibly indicating the
selection of a population at especially high baseline risk and
likely reflecting the absence of anticoagulation.
Second, confirmation by transesophageal echocardiogra-
phy of effective obliteration of the left atrial appendage was
obtained in only 5 of the 15 patients at the time of the
stroke, leaving the possibility that thrombus in the surgical
stump may have contributed to the clinical event in the
others. Factors that affect the likelihood of atrial fibrillation
recurrence and left atrial function, such as the duration of
atrial fibrillation (10) before surgery and low amplitude of
fibrillatory waves on electrocardiography (8,10), were not
considered in the analysis.
Finally, like other studies of this type, this was a single-
center study, a circumstance that always affects the gener-
alizability of the results. Even with these limitations, the
stroke risk stratification on the basis of left atrial size and
function assessment proposed by Buber et al. (5) appears
reasonable, with the advantage of being based solely on
transthoracic echocardiography, a noninvasive test that can
easily be performed during the follow-up. Patients with
absent LAMC and/or very large atrial volumes might be
candidates for further assessment by transesophageal echo-
cardiography, looking for more direct stroke risk indicators,
such as spontaneous echo contrast or thrombus in the
surgical stump of the appendage, which would further refine
the risk prediction and guide the decision to initiate oral
anticoagulation. The use of anticoagulation solely on the
basis of absent LAMC or large atrial size, although not
unreasonable on the basis of the results of Buber et al. (5),
will require validation in appositely designed prospective
studies.The field of surgical treatment of atrial fibrillation is
rapidly evolving. Better understanding of the mechanisms of
atrial fibrillation and more accurate pre-operative identifi-
cation of the region of origin of the arrhythmia will lead to
the refinement and possibly individualization of surgical
techniques. Minimally invasive or thoracoscopic ap-
proaches, and possibly the elimination of cardiopulmonary
bypass, already a reality for pulmonary vein isolation and left
atrial appendage excision (3), may make the surgical option
available to a larger number of patients, offering a viable
alternative to transcatheter techniques or drug treatment in
selected patients. A more complete understanding of the
effects of surgical ablation on atrial electrophysiology and
function will be critical to the success of these techniques,
both in restoring normal sinus rhythm and decreasing the
risk for atrial fibrillation’s most dreaded complication—
thromboembolic stroke.
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